AXQ Capital LP Purchases New Holdings in Rxo Inc $RXO

AXQ Capital LP purchased a new stake in Rxo Inc (NYSE:RXO) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 20,153 shares of the company’s stock, valued at approximately $317,000.

Several other institutional investors also recently modified their holdings of RXO. Yousif Capital Management LLC increased its position in shares of RXO by 1.2% during the second quarter. Yousif Capital Management LLC now owns 53,228 shares of the company’s stock valued at $837,000 after purchasing an additional 631 shares during the period. Thurston Springer Miller Herd & Titak Inc. boosted its stake in RXO by 25.1% during the second quarter. Thurston Springer Miller Herd & Titak Inc. now owns 3,433 shares of the company’s stock worth $54,000 after buying an additional 688 shares in the last quarter. Maryland State Retirement & Pension System boosted its stake in RXO by 1.8% during the second quarter. Maryland State Retirement & Pension System now owns 41,910 shares of the company’s stock worth $659,000 after buying an additional 751 shares in the last quarter. Teacher Retirement System of Texas increased its holdings in RXO by 5.8% in the 2nd quarter. Teacher Retirement System of Texas now owns 16,154 shares of the company’s stock valued at $254,000 after buying an additional 892 shares during the period. Finally, Kirr Marbach & Co. LLC IN increased its holdings in RXO by 0.6% in the 2nd quarter. Kirr Marbach & Co. LLC IN now owns 189,980 shares of the company’s stock valued at $2,986,000 after buying an additional 1,154 shares during the period. Institutional investors and hedge funds own 92.73% of the company’s stock.

Insiders Place Their Bets

In related news, Director Troy A. Cooper acquired 8,317 shares of the stock in a transaction on Thursday, November 20th. The stock was purchased at an average price of $10.61 per share, for a total transaction of $88,243.37. Following the transaction, the director owned 275,416 shares of the company’s stock, valued at $2,922,163.76. The trade was a 3.11% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Thomas A. Szlosek bought 20,308 shares of the company’s stock in a transaction on Friday, November 7th. The stock was bought at an average cost of $12.37 per share, with a total value of $251,209.96. Following the completion of the purchase, the director owned 36,508 shares of the company’s stock, valued at approximately $451,603.96. The trade was a 125.36% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased a total of 40,250 shares of company stock valued at $488,875 in the last 90 days. 1.48% of the stock is currently owned by insiders.

RXO Trading Up 5.8%

Shares of RXO opened at $12.13 on Tuesday. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.32 and a current ratio of 1.32. The company has a market cap of $1.99 billion, a price-to-earnings ratio of -28.21 and a beta of 1.66. The stock has a fifty day moving average price of $15.53 and a two-hundred day moving average price of $15.86. Rxo Inc has a 52-week low of $10.43 and a 52-week high of $31.11.

RXO (NYSE:RXO) last announced its earnings results on Thursday, November 6th. The company reported $0.01 EPS for the quarter, missing the consensus estimate of $0.03 by ($0.02). RXO had a positive return on equity of 0.88% and a negative net margin of 1.25%.The business had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.44 billion. During the same quarter in the previous year, the company posted $0.05 EPS. RXO’s revenue for the quarter was up 34.6% on a year-over-year basis. Analysts predict that Rxo Inc will post 0.31 EPS for the current fiscal year.

Analyst Ratings Changes

RXO has been the topic of several recent research reports. Wolfe Research upgraded shares of RXO from an “underperform” rating to a “peer perform” rating in a research report on Friday, November 14th. Zacks Research lowered shares of RXO from a “hold” rating to a “strong sell” rating in a research report on Thursday, November 6th. Stifel Nicolaus lifted their price objective on RXO from $14.00 to $17.00 and gave the company a “hold” rating in a report on Friday, October 10th. JPMorgan Chase & Co. upped their price objective on RXO from $15.00 to $16.00 and gave the company an “underweight” rating in a research note on Wednesday, October 8th. Finally, Barclays dropped their target price on RXO from $17.00 to $15.00 and set an “overweight” rating for the company in a report on Friday, November 7th. Four analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $16.69.

About RXO

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.